Port-a-Cath / Central Line Insertion
Surgical insertion of a subcutaneous venous access port or central venous catheter providing reliable long-term intravenous access for chemotherapy administration, blood sampling, and supportive infusions.
Overview
Overview
Port-a-Cath and Central Line Insertion is a minor surgical procedure to place a central venous access device (CVAD) providing safe, reliable, and comfortable long-term intravenous access for the administration of chemotherapy, blood products, intravenous medications, and blood sampling throughout the cancer treatment course. A Port-a-Cath is a small chamber implanted completely beneath the skin and accessed through the skin with a Huber needle, eliminating the need for repeated peripheral cannulation with each treatment cycle. The device is placed under local anaesthesia with ultrasound and fluoroscopic guidance as a day-case procedure, and it remains in place for the full duration of chemotherapy treatment.
Types of Port-a-Cath / Central Line Insertion
- Port-a-Cath (totally implantable venous access port) — completely implanted beneath the skin; accessed with a Huber needle; ideal for long-term intermittent chemotherapy
- PICC line (peripherally inserted central catheter) — inserted via an arm vein with the tip positioned in the superior vena cava; suitable for weeks to months of continuous treatment
- Hickman line (tunnelled central venous catheter) — exits through the chest wall via a subcutaneous tunnel; used for intensive regimens requiring frequent daily access
- Non-tunnelled central venous catheter — short-term inpatient access device for acute inpatient chemotherapy administration
- Power-injectable implantable port — allows high-flow contrast injection for CT scanning in addition to chemotherapy administration
Risk Factors of Port-a-Cath / Central Line Insertion
- Planned course of intravenous chemotherapy requiring multiple cycles of treatment over weeks or months
- Vesicant chemotherapy agents (anthracyclines, vinca alkaloids) causing severe irreversible tissue damage if extravasated peripherally
- Poor or difficult peripheral venous access due to previous chemotherapy courses, obesity, or extensive needle phobia
- Requirement for continuous intravenous infusion such as 46-hour 5-fluorouracil or total parenteral nutrition
- Haematological malignancy requiring frequent daily blood sampling and multiple simultaneous intravenous medications
- Paediatric oncology patients where repeated peripheral cannulation causes significant procedural distress and anxiety
Symptoms of Port-a-Cath / Central Line Insertion
- Pain, redness, swelling, or purulent discharge at the port pocket or catheter exit site suggesting infection
- Inability to aspirate blood or flush the device suggesting catheter blockage, fibrin sheath formation, or malposition
- Fever and systemic signs of infection (rigors, haemodynamic instability) suggesting catheter-related bloodstream infection
- New chest pain and breathlessness following port insertion suggesting pneumothorax or haemothorax requiring urgent X-ray
- Ipsilateral arm swelling, pain, and erythema suggesting upper extremity deep vein thrombosis around the catheter
- Leaking of fluid around the port needle access site or catheter exit suggesting poor needle placement or device damage
- Shoulder and neck pain on the same side as the port suggesting catheter tip migration or venous thrombosis
- Cardiac arrhythmias during or after port insertion suggesting catheter tip malposition in the right atrium or ventricle
Key Benefits
Discover the advantages of choosing our port-a-cath / central line insertion services.
Reliable long-term venous access avoids repeated peripheral cannula placement for every chemotherapy cycle
Port-a-Cath completely implanted beneath the skin allowing unrestricted showering and swimming
Reduced extravasation risk from vesicant chemotherapy through correctly positioned central line
Enables blood sampling without repeated peripheral venepuncture throughout the treatment course
Single procedure under local anaesthesia provides access for the entire duration of chemotherapy
Clinical Features
The technology, techniques and clinical approach behind our port-a-cath / central line insertion.
Real-time ultrasound guidance for vascular access reducing procedure-related complications
Fluoroscopic catheter tip confirmation at the cavoatrial junction before device use
Chest X-ray post-procedure to confirm position and exclude pneumothorax
Dissolvable sutures used for wound closure avoiding a suture removal appointment
Written CVAD care instructions and identification card provided before discharge
Preparation Instructions
Fast from midnight before the insertion procedure or as instructed. Wear loose comfortable clothing with easy access to the upper chest or arm. Arrange transport home as driving is not permitted on the day of the procedure. A blood test confirming normal clotting is required before the procedure.
The Procedure
Step-by-step guide to what you can expect during your port-a-cath / central line insertion procedure.
Pre-Procedure Assessment and Consent
Clotting screen blood count renal function and blood pressure are reviewed. The most appropriate central venous access device type is discussed based on chemotherapy regimen treatment duration patient preference and anatomy.
Ultrasound-Guided Vascular Access
Real-time ultrasound guidance is used to identify the internal jugular or subclavian vein -- visualising the vessel lumen and guiding the needle into the vessel under continuous imaging to reduce complication risk.
Fluoroscopic Catheter Tip Positioning
Under fluoroscopy the catheter tip position is confirmed at the cavoatrial junction -- the ideal position providing adequate dilution of vesicant chemotherapy agents and reliable blood return for sampling.
Port Pocket Creation or Catheter Tunnelling
For a totally implantable port a small subcutaneous pocket is created below the clavicle under local anaesthesia. For tunnelled catheters the catheter is tunnelled subcutaneously from the vessel entry point to the chest wall exit site.
Wound Closure and Post-Procedure Chest X-Ray
Incisions are closed with dissolvable sutures and sterile dressings applied. A chest X-ray confirms correct catheter tip position and excludes pneumothorax before any drugs are administered through the new device.
Patient Education on Device Care
Written instructions on port flushing schedule signs of infection correct access technique and activity restrictions are provided. The importance of carrying the CVAD identification card at all times is emphasised.
What to Expect
Local anaesthetic numbs the insertion site and light sedation provides comfort. The port or catheter is placed using ultrasound guidance. A chest X-ray confirms correct tip position before any drugs are administered through the device. The procedure takes 45 to 60 minutes and you recover in the day unit for 1 to 2 hours before discharge.
Recovery
Keep the wound dry for 5 to 7 days. Report redness, swelling, warmth, discharge at the insertion site, new chest pain, breathlessness, or fever to the oncology team immediately. The port requires regular flushing (monthly when not in use) by a trained nurse. Do not allow non-trained staff to access your port. Carry your CVAD identification card at all times.
Frequently Asked Questions
Common questions about port-a-cath / central line insertion.
Related Services
Explore other services in our Oncology department.
Chemotherapy Administration
Radiation Therapy
Cancer Staging and Tumour Marker Assessment
Ready to Get Started?
Schedule your consultation today and take the first step towards better health.